We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.97%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$126B
AUM Growth
+$5.23B
(+4.3%)
Cap. Flow
-$4.63B
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
346
New
11
Increased
124
Reduced
177
Closed
13
Avg Time Held
6.9
years
Top 10 Avg Time Held
4.3
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles Schwab
SCHW
|
+$421M |
| 2 |
Amazon
AMZN
|
+$401M |
| 3 |
ConocoPhillips
COP
|
+$282M |
| 4 |
Danaher
DHR
|
+$217M |
| 5 |
Flutter Entertainment
FLUT
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.04B |
| 2 |
Sony
SONY
|
+$581M |
| 3 |
Micron Technology
MU
|
+$543M |
| 4 |
Amgen
AMGN
|
+$498M |
| 5 |
Adobe
ADBE
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.56% |
| 2 | Healthcare | 25.76% |
| 3 | Industrials | 11.23% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Immunome
IMNM
$2.05B
| $28.1M | 0.02% |
3,020,210
-393,490
| -12% | -$3.23M |
2024 Q1
5 quarters
|
|
227
Kirby Corp
KEX
$7.24B
| $27.4M | 0.02% |
241,853
-22,497
| -9% | -$2.36M |
2020 Q4
18 quarters
|
|
228
Credo Technology Group
CRDO
$33.5B
| $26.9M | 0.02% |
290,000
-163,450
| -36% | -$9.53M |
2022 Q2
12 quarters
|
|
229
Parsons
PSN
$4.71B
| $25.6M | 0.02% |
357,100
+22,300
| +7% | +$1.47M |
2025 Q1
1 quarter
|
|
230
BridgeBio Pharma
BBIO
$13.1B
| $25.4M | 0.02% |
588,710
-324,490
| -36% | -$11.8M |
2021 Q1
17 quarters
|
|
231
Humana
HUM
$51.9B
| $24.6M | 0.02% |
100,650
+81,324
| +421% | +$20.3M |
2021 Q2
16 quarters
|
|
232
Take-Two Interactive
TTWO
$39.1B
| $24M | 0.02% |
98,859
+35,000
| +55% | +$7.89M |
2024 Q4
2 quarters
|
|
233
Tyson Foods
TSN
$19B
| $23.4M | 0.02% |
418,500
-5,000
| -1% | -$287K |
2014 Q4
42 quarters
|
|
234
VSE Corp
VSEC
$4.53B
| $23M | 0.02% |
175,338
+6,173
| +4% | +$769K |
2024 Q3
3 quarters
|
|
235
Altria Group
MO
$123B
| $21.7M | 0.02% |
370,900
-6,600
| -2% | -$388K |
2017 Q2
32 quarters
|
|
236
Tapestry
TPR
$23.8B
| $21.7M | 0.02% |
247,140
-110,355
| -31% | -$8.36M |
2023 Q4
6 quarters
|
|
237
Tronox
TROX
$565M
| $21.6M | 0.02% |
4,252,502
+2,797,002
| +192% | +$15.2M |
2023 Q3
7 quarters
|
|
238
IMAX
IMAX
$2.83B
| $21M | 0.02% |
751,602
+9,902
| +1% | +$257K |
2016 Q1
37 quarters
|
|
239
DELISTED
CyberArk
CYBR
| $20.7M | 0.02% |
50,856
-8,234
| -14% | -$3M |
2019 Q4
22 quarters
|
|
240
Griffon
GFF
$4.22B
| $20.5M | 0.02% |
283,589
+8,389
| +3% | +$584K |
2023 Q2
8 quarters
|
|
241
DELISTED
Exact Sciences
EXAS
| $20.1M | 0.02% |
378,400
-100,900
| -21% | -$5.13M |
2014 Q2
44 quarters
|
|
242
Trade Desk
TTD
$6.21B
| $18.4M | 0.01% |
254,925
+45,925
| +22% | +$2.93M |
2023 Q1
9 quarters
|
|
243
Flywire
FLYW
$2.35B
| $18M | 0.01% |
1,537,240
-258,610
| -14% | -$2.63M |
2022 Q2
12 quarters
|
|
244
HubSpot
HUBS
$11.9B
| $17.9M | 0.01% |
32,150
-12,900
| -29% | -$7.56M |
2016 Q1
37 quarters
|
|
245
Sphere Entertainment
SPHR
$3.91B
| $17.5M | 0.01% |
419,498
-3,410
| -0.8% | -$115K |
2023 Q2
8 quarters
|
|
246
Repligen
RGEN
$11.7B
| $17.2M | 0.01% |
138,278
+107,420
| +348% | +$13.7M |
2021 Q2
16 quarters
|
|
247
Waters Corp
WAT
$43.6B
| $17.1M | 0.01% |
49,047
-19,854
| -29% | -$6.83M |
2020 Q4
18 quarters
|
|
248
MaxLinear
MXL
$7.09B
| $16.9M | 0.01% |
1,188,798
-493,082
| -29% | -$5.69M |
2016 Q4
34 quarters
|
|
249
Gartner
IT
$13.1B
| $16.4M | 0.01% |
40,500
-66,000
| -62% | -$27.6M |
2023 Q4
6 quarters
|
|
250
Wave Life Sciences
WVE
$629M
| $16M | 0.01% |
2,465,850
-41,670
| -2% | -$275K |
2019 Q3
23 quarters
|
|
Similar funds
Primecap Management's Q2 2025 Portfolio in Review
As of Q2 2025, Primecap Management held 346 positions worth $126B, up 4.3% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $4.63B in Q2 2025, closing 13 positions and reducing 177 holdings. Its most notable exit was Discover Financial Services, an estimated $98.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Capital One worth $116M.
- Primecap Management's largest Q2 2025 buy was Capital One: 545,321 shares worth $116M.
- Primecap Management added most to Charles Schwab in Q2 2025, an estimated $421M increase.
- Primecap Management's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $2.04B.
- Primecap Management fully exited Discover Financial Services in Q2 2025, selling an estimated $98.1M.
- Primecap Management's ten largest holdings make up 32% of its $126B portfolio in Q2 2025.
- Primecap Management opened 11 new positions and closed 13 in Q2 2025.
- Primecap Management's portfolio value rose 4.3% quarter-over-quarter to $126B.
Based on Primecap Management's 13F filing for Q2 2025, filed 11 Aug 2025.